Myasthenia Gravis survival is better than Multiple Sclerosis in new data. Patients with MG live 15 to 19 years longer than MS…
FDA approves rusfertide (Mimrylo) for erythrocytosis, sparing polycythemia vera patients from painful phlebotomies. Read the latest medical news.
A new AACR Lung Cancer Task Force roadmap outlines key research priorities to close the survival gap and improve patient outcomes.
Global study reveals significant challenges in managing leukemia therapies and care capabilities across different countries and clinical settings.
The tragic death of an uninsured patient exposes a charity care gap in the U.S., where essential outpatient services are denied, urging…